Analytical Data
-
基因名
COL11a2
- Application
-
别名
COL11-A2; DFNA13; DFNB53; HKE5; Collagen Alpha-2(XI)chain
-
种属
Human
-
表达系统
E. coli
-
标签
N-His
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
P13942
-
表达区间
Met1~Gln266
-
分子量
38kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
COL11A2, a type of collagen, is primarily expressed in various tissues during development and plays a crucial role in the formation of extracellular matrix structures. Its specific involvement in cartilage formation and maintenance has been of substantial interest in the context of skeletal disorders, particularly in conditions like osteoarthritis and chondrodysplasias. Research has shown that mutations in the COL11A2 gene can lead to significant abnormalities in the collagen structure, impacting the integrity and functionality of cartilage tissue. The recombinant COL11A2 protein has emerged as a valuable tool for studying the molecular mechanisms underlying cartilage development and degeneration. By generating this protein through recombinant DNA technology, researchers can explore its biochemical properties, interactions with other extracellular matrix components, and its role in cellular behaviors such as proliferation and differentiation of chondrocytes. Moreover, recombinant COL11A2 can serve as a potential candidate for tissue engineering applications, offering insights into the development of regenerative therapies for cartilage repair. Thus, studies involving COL11A2 recombinant protein are pivotal for advancing our understanding of cartilage biology and developing innovative approaches to combat cartilage-related diseases.












